M-K. Ang - Medical Oncology Department, NCCS - National Cancer Centre Singapore, Singapore

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

924P Claudin-1 (CLDN1) Tight Junction Protein Expression Delineates Distinct Immune Infiltrates in Ascending (A) Vs Descending (D) Subtypes of Nasopharyngeal Carcinoma: Potential Implications for Treatment Selection

D.W-T. Lim, E. Yeo, J. Neo, E. Ong, W.M. Chow, K.M. Tan, J. Tan,J.P.S. Yeong,T.K.H. Lim, J.S.G. Hwang, Q.S. Ng,Y.L. Soong,M-K. Ang, S.H. Tan,M.L.K. Chua

Annals of Oncology (2024)

引用0浏览0引用

230P Clinicopathologic and Molecular Features of STK11-mutated NSCLC

P.L.S. Saw, M. Pang,G.S. Tan,N.L. Sim, C. Patteri, G. Lai,A. Tan,J. Chan,W.L. Tan,Q.S. Ng,M-K. Ang,D.W-T. Lim,T.K.H. Lim,A. Skanderup,D.S.W. Tan

ESMO Open (2024)

引用0浏览0引用

911P Post-radiotherapy (RT) Epstein-Barr Virus (EBV) DNA Dynamics Identifies Optimal Timepoint for Stratification of High-Risk Nasopharyngeal Carcinoma (NPC)

J. S. H. Tan, J. Neo,E. H. W. Ong, W. M. Chow,K. W. Fong,Y. L. Soong,S. Y. Sin,D. S. W. Tan,M-K. Ang,S. H. Tan,D. W-T. Lim,M. L. K. Chua

Annals of Oncology (2023)

引用0浏览0引用

192P Ddpcr Versus Plasma NGS in Detecting Clearance of Plasma EGFR Mutations

P. L. S. Saw, G. S. Tan,A. Tan,G. Lai, W. C. Tan,E. H. Tan,M-K. Ang,D. W-T. Lim,R. Kanesvaran,Q. S. Ng,A. Jain,W. L. Tan,T. Rajasekaran, J. Chan,Y. L. Teh,S. H. Tan,T. K. H. Lim,D. S. W. Tan

Journal of Thoracic Oncologyno. 4 (2023)

引用1浏览0引用

227MO Characterization of Minimal Residual Disease (MRD) Post-Radiotherapy (RT) in Nasopharyngeal Carcinoma (NPC) Patients Identifies a Favorable Subgroup with Low Risk of Relapse

J. Neo,E. Ong,A. Sim, J. J. Miao,J. T. S. Wee,K. W. Fong,Y. L. Soong,S. Y. Sin,D. S. W. Tan,D. W-T. Lim,M-K. Ang,M. L. K. Chua

Annals of oncology (2022): S1523-S1523

引用0浏览0引用

652O Randomized Phase III VANCE Study: Gemcitabine and Carboplatin (GC) Followed by Epstein Barr Virus-Specific Autologous Cytotoxic T Lymphocytes (EBV-CTL) Versus the Same Chemotherapy As First-Line Treatment for Advanced Nasopharyngeal Carcinoma (NPC)

H. C. Toh,M-H. Yang,H-M. Wang,C-Y. Hsieh,I. Chitapanarux,K. F. Ho,R-L. Hong,M-K. Ang,D. Colevas,E. Sirachainan,C. Lertbutsayanukul,G. F. Ho,J. Samol, Z. Huang, C. Tan, C. Ding, A. Myo

Annals of Oncology (2022): S840-S840

引用0浏览0引用

266O Combination Ipilimumab and Nivolumab in Recurrent/metastatic Nasopharyngeal Carcinoma (R/M NPC): Updated Efficacy and Safety Analysis of NCT03097939

H-F. Kao,M-K. Ang,Q. S. Ng,D. S. W. Tan,W. Tan,T. Rajasekaran,A. Jain,B-C. Liao,S. H. Tan,E-H. Tan,N. G. Iyer,M. L. K. Chua,R-L. Hong,D. W-T. Lim

Annals of oncology（2020）

引用9浏览0引用

Real World Data on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKI) Use in Advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations in Singapore

B. Chua,E. H. Tan,D. W-T. Lim,M-K. Ang,D. S. W. Tan,Q-S. Ng,R. Kanesvaran,A. Jain,W-L. Tan,C. K. Toh,T. Rajasekaran

Annals of Oncology（2018）

引用7浏览0WOS引用

T790M Co-Exists with Other Secondary Resistance Mechanisms in EGFR Mutation Positive NSCLC and Are Associated with Inferior Outcomes

R. Teng,A. Takano,W-L. Tan,M-K. Ang,C-K. Toh, Q-S. Ng,W-T. Lim,E-H. Tan,T. Lim,D. Tan

Annals of Oncology（2017）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn